A national cross-sectional survey reveals gaps in cardiotoxicity management between cardiologists and oncologists, highlighting a need for improved multidisciplinary collaboration.
Key Points
Only 10.1% of physicians reported the presence of cardio-oncology teams across Romania, revealing significant gaps in multidisciplinary collaboration.
76.9% of oncologists do not prescribe prophylactic medication for high CV-risk patients compared to 25.1% of cardiologists, showcasing differing therapeutic strategies.
Oncologists predominantly utilize biomarkers (71.7%) to assess subclinical CV toxicity, while cardiologists prefer a broader diagnostic approach.
There is substantial agreement among respondents about the necessity for outpatient clinics specializing in cardio-oncology, indicating a common goal for improving patient outcomes.